Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitonin for bone union after proximal tibial osteotomy
IRCT20200305046700N9Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of calcitonin salmon in Tibial deformity (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Degree of bone union. Started Oct 2025; status: recruiting.
02
Drugs
calcitonin salmon
03
Conditions
Tibial deformity
Beyond the preview
Go deeper on IRCT20200305046700N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200305046700N9.